A Study to Induce Tolerance in de Novo Renal Transplantation
Status:
Not yet recruiting
Trial end date:
2027-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if TCD601with donor bone marrow and conditioning
using fludarabine and cyclophosphamide can induce allogeneic tolerance in de novo living
donor renal transplant recipients